Global Expression Profile of Highly Enriched Cardiomyocytes Derived from Human Embryonic Stem Cells
Open Access
- 5 August 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 27 (9) , 2163-2174
Abstract
Human embryonic stem cells (hESC), with their ability to differentiate into cardiomyocytes in culture, hold great potential for cell replacement therapies and provide an in vitro model of human heart development. A genomewide characterization of the molecular phenotype of hESC-derived cardiomyocytes is important for their envisioned applications. We have employed a lineage selection strategy to generate a pure population of cardiomyocytes (>99%) from transgenic hESC lines. Global gene expression profiling showed that these cardiomyocytes are distinct from pluripotent and differentiated hESC cultures. Pure cardiomyocytes displayed similarities with heart tissue, but in many aspects presented an individual transcriptome pattern. A subset of 1,311 cardiac-enriched transcripts was identified, which were significantly overpresented (p < .01) in the Gene Ontology (GO) categories of heart function and heart development. Focused analysis of the GO categories ion transport, sarcomere, and heart development uncovered a unique molecular signature of hESC cardiomyocytes. Pathway analysis revealed an extensive cardiac transcription factor network and novel peroxisome proliferator-activated receptor signaling components within the cardiac-enriched genes. Notably, approximately 80% of these genes were previously uncharacterized. We have evaluated the biological relevance of four candidates—Rbm24, Tcea3, Fhod3, and C15orf52—by in situ hybridization during early mouse development and report that all were prominently expressed in cardiac structures. Our results provide the fundamental basis for a comprehensive understanding of gene expression patterns of hESC cardiomyocytes and will greatly help define biological processes and signaling pathways involved in hESC cardiomyogenic differentiation and in human heart development. STEM CELLS 2009;27:2163–2174Keywords
This publication has 28 references indexed in Scilit:
- Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cellsDifferentiation, 2008
- Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived CardiomyocytesPLOS ONE, 2008
- Molecular Signature of Cardiomyocyte Clusters Derived from Human Embryonic Stem CellsStem Cells, 2008
- Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPKDifferentiation, 2008
- Highly enriched cardiomyocytes from human embryonic stem cellsCytotherapy, 2008
- Prostaglandins PGE2 and PGI2 promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activationExperimental Cell Research, 2007
- Genome‐Wide Transcriptional Profiling of Human Embryonic Stem Cells Differentiating to CardiomyocytesStem Cells, 2006
- A DNA microarray survey of gene expression in normal human tissuesGenome Biology, 2005
- Micro-Electrode Arrays in Cardiac Safety PharmacologyDrug Safety, 2004
- Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategiesCytotherapy, 2003